Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Hepatology|June 18, 2013
Liver as a target for oligonucleotide therapeuticsAlfica Sehgal, Akshay Vaishnaw, Kevin Fitzgerald
Nature Biotechnology|February 27, 2024
RNA interference in the era of nucleic acid therapeuticsVasant Jadhav, Akshay Vaishnaw, Kevin Fitzgerald, et al.
Arthritis and Rheumatism|July 13, 2002
The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosusWeiqing Huang, Jayashree Sinha, Jeffrey Newman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2010
A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virusJohn DeVincenzo, Robert Lambkin-Williams, Tom Wilkinson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
Clinical Proof of Concept for a Novel Hepatocyte-Targeting GalNAc-siRNA ConjugateTracy S Zimmermann, Verena Karsten, Amy Chan, et al.
The Journal of Infectious Diseases|May 16, 2015
Effect of Preexisting Serum and Mucosal Antibody on Experimental Respiratory Syncytial Virus (RSV) Challenge and Infection of AdultsBindiya Bagga, Jeffrey E Cehelsky, Akshay Vaishnaw, et al.
American Journal of Respiratory and Critical Care Medicine|September 21, 2010
RNA interference therapy in lung transplant patients infected with respiratory syncytial virusMartin R Zamora, Marie Budev, Mark Rolfe, et al.
Orphanet Journal of Rare Diseases|September 5, 2015
Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose studyOle B Suhr, Teresa Coelho, Juan Buades, et al.
Neurology|October 22, 2020
Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated AmyloidosisSimina Ticau, Gautham V Sridharan, Shira Tsour, et al.
Pageof 2